{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:10:12Z","timestamp":1759342212406,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.revmed.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:22:23Z","timestamp":1340756543000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["D\u00e9ficits immunitaires primitifs et cytop\u00e9nies auto-immunes de l\u2019adulte"],"prefix":"10.1016","volume":"34","author":[{"given":"P.","family":"S\u00e8ve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2012.05.007_bib0005","doi-asserted-by":"crossref","unstructured":"Notarangelo LD. Primary immunodeficiencies (PIDs) presenting with cytopenias. Hematology Am Soc Hematol Educ Program 2009:139\u201343.","DOI":"10.1182\/asheducation-2009.1.139"},{"key":"10.1016\/j.revmed.2012.05.007_bib0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.111.5.e622","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55\u00a0patients","volume":"111","author":"Dupuis-Girod","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2012.05.007_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79\u00a0patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2012.05.007_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-200103000-00005","article-title":"Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5\u00a0cases and review of the literature","volume":"80","author":"Tarr","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.autrev.2008.11.004","article-title":"Autoimmune manifestations in primary immune deficiencies","volume":"8","author":"Bussone","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1007\/s10875-008-9172-9","article-title":"Autoimmunity in common variable immunodeficiency","volume":"28","author":"Lopes-da-Silva","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2010.10.002","article-title":"Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study","volume":"36","author":"Boileau","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2012.05.007_bib0055","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaci.2011.02.039","article-title":"Genome-wide association identifies diverse causes of common variable immunodeficiency","volume":"127","author":"Orange","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.md.0000133624.65946.40","article-title":"Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21\u00a0cases and review of the literature","volume":"83","author":"Michel","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.revmed.2004.11.001","article-title":"Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients","volume":"26","author":"Pavic","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.05.007_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MD.0b013e31817a90ba","article-title":"Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18\u00a0patients","volume":"87","author":"Seve","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2012.05.007_bib0080","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68\u00a0cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2005.04.006","article-title":"Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID)","volume":"25","author":"Wang","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17474086.1.2.189","article-title":"Autoimmune hemolytic anemia: classification and therapeutic approaches","volume":"1","author":"Seve","year":"2008","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0095","unstructured":"Sant\u00e9 HAS. Protocole national de diagnostic et de soins (PNDS) ALD no\u00a02 - Purpura thrombop\u00e9nique immunologique de l\u2019enfant et de l\u2019adulte. 2009."},{"key":"10.1016\/j.revmed.2012.05.007_bib0100","first-page":"259","article-title":"Successful use of rituximab in refractory idiopathic thrombocytopenic purpura in a patient with common variable immunodeficiency","volume":"20","author":"Al-Ahmad","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2141.2007.06616.x","article-title":"Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency","volume":"138","author":"Kim","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.20072","article-title":"Successful anti-CD20\u00a0monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency","volume":"76","author":"Wakim","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ajh.20619","article-title":"Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency","volume":"81","author":"Mahevas","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0250","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33\u00a0patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","article-title":"How I treat autoimmune lymphoproliferative syndrome","volume":"118","author":"Rao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2010.03.013","article-title":"ALPS-ten lessons from an international workshop on a genetic disease of apoptosis","volume":"32","author":"Lenardo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.revmed.2012.05.007_bib0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-3476(67)80262-2","article-title":"Chronic lymphadenopathy simulating malignant lymphoma","volume":"70","author":"Canale","year":"1967","journal-title":"J Pediatr"},{"key":"10.1016\/j.revmed.2012.05.007_bib0140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1172\/JCI115867","article-title":"A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease","volume":"90","author":"Sneller","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2012.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","article-title":"Mutations in FAS associated with human lymphoproliferative syndrome and autoimmunity","volume":"268","author":"Rieux-Laucat","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.revmed.2012.05.007_bib0150","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2010-01-263145","article-title":"Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome","volume":"115","author":"Dowdell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI43752","article-title":"Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation","volume":"121","author":"Magerus-Chatinet","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.revmed.2012.05.007_bib0255","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009\u00a0NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0165","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood-2008-09-179630","article-title":"FAS-L, IL-10, and double-negative CD4\u2212 CD8\u2212 TCR alpha\/beta+ T-cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function","volume":"113","author":"Magerus-Chatinet","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0170","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A survey of 90\u00a0patients with autoimmune lymphoproliferative syndrome related to TNFRSF6\u00a0mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.revmed.2010.10.131","article-title":"Syndrome lymphoprolif\u00e9ratif auto-immun chez l\u2019adulte\u00a0: une cause rare mais sous-diagnostiqu\u00e9e de cytop\u00e9nies auto-immunes","volume":"31S","author":"Lambotte","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2012.05.007_bib0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0022-3859.81873","article-title":"Autoimmune lymphoproliferative disorder in an adult patient","volume":"57","author":"Desai","year":"2011","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.revmed.2012.05.007_bib0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-003-0830-2","article-title":"The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood","volume":"23","author":"Deutsch","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/0003-4819-130-7-199904060-00020","article-title":"An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome","volume":"130","author":"Straus","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2012.05.007_bib0195","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1182\/blood-2009-08-239525","article-title":"Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study","volume":"115","author":"Seif","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0200","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0031-3955(05)70272-8","article-title":"Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival","volume":"47","author":"Bleesing","year":"2000","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.revmed.2012.05.007_bib0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2009.07991.x","article-title":"Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)","volume":"148","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0210","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1182\/blood.V89.4.1341","article-title":"Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis","volume":"89","author":"Sneller","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2005.05496.x","article-title":"Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome","volume":"129","author":"Rao","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0220","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MPH.0b013e31802d7503","article-title":"Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome","volume":"28","author":"Kossiva","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/pbc.22151","article-title":"Rapid regression of lymphadenopathy upon rapamycin treatment in a child with autoimmune lymphoproliferative syndrome","volume":"53","author":"Janic","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.revmed.2012.05.007_bib0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2141.2009.07595.x","article-title":"Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome","volume":"145","author":"Teachey","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2012.05.007_bib0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline FAS mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2012.05.007_bib0240","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/pbc.21965","article-title":"Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)","volume":"52","author":"Rao","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.revmed.2012.05.007_bib0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.clim.2010.08.008","article-title":"Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency","volume":"137","author":"Rensing-Ehl","year":"2010","journal-title":"Clin Immunol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312005231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866312005231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:43Z","timestamp":1759336243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866312005231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0248866312005231"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2012.05.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D\u00e9ficits immunitaires primitifs et cytop\u00e9nies auto-immunes de l\u2019adulte","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2012.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}